Edgar Lomax CO Gilead Sciences, Inc. Transaction History

Edgar Lomax CO

$1.63 Billion
Q3 2024

A detailed history of Edgar Lomax CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Edgar Lomax CO holds 127,990 shares of GILD stock, worth $11.5 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

127,990

Previous 129,980 1.53%

Holding current value

$11.5 Million

Previous $8.92 Million 20.31%

% of portfolio

0.66%

Previous 0.58%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $132,514 - $167,140	-1,990 Reduced 1.53%	127,990 $10.7 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $147,139 - $169,810	-2,330 Reduced 1.76%	129,980 $8.92 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $2.32 Million - $2.83 Million	32,411 Added 32.44%	132,310 $9.69 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $294,911 - $334,437	-4,025 Reduced 3.87%	99,899 $8.09 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $129,025 - $140,769	-1,745 Reduced 1.65%	103,924 $7.79 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $107,630 - $122,767	-1,416 Reduced 1.32%	105,669 $8.14 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $8.92 Million - $10.2 Million	-115,415 Reduced 51.87%	107,085 $8.88 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $80,392 - $115,416	-1,290 Reduced 0.58%	222,500 $19.1 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $151,529 - $173,085	-2,545 Reduced 1.12%	223,790 $13.8 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $356,709 - $401,761	6,180 Added 2.81%	226,335 $14 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $3.49 Million - $4.38 Million	60,335 Added 37.75%	220,155 $13.1 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $98,293 - $111,564	-1,515 Reduced 0.94%	159,820 $11.6 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $199,685 - $215,438	-2,950 Reduced 1.8%	161,335 $11.3 Million
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $403,034 - $440,372	-6,350 Reduced 3.72%	164,285 $11.3 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $268,800 - $306,700	-4,480 Reduced 2.56%	170,635 $11 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $172,782 - $196,877	-3,050 Reduced 1.71%	175,115 $10.2 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $447,120 - $562,176	7,200 Added 4.21%	178,165 $11.3 Million
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $239,807 - $278,460	3,315 Added 1.98%	170,965 $13.2 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.49 Million - $1.91 Million	23,800 Added 16.55%	167,650 $12.5 Million
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $209,508 - $230,452	-3,400 Reduced 2.31%	143,850 $9.35 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $93,765 - $103,500	-1,500 Reduced 1.01%	147,250 $9.33 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $139,207 - $156,105	-2,250 Reduced 1.49%	148,750 $10.1 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.33 Million - $1.49 Million	21,300 Added 16.42%	151,000 $9.82 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $115,026 - $150,100	-1,900 Reduced 1.44%	129,700 $8.11 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $320,760 - $355,140	-4,500 Reduced 3.31%	131,600 $10.2 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $61,635 - $71,896	950 Added 0.7%	136,100 $9.64 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $9.84 Million - $12 Million	135,150 New	135,150 $10.2 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.

Account